The Infectious Diseases Society of America published new guidance this week for the treatment of antimicrobial-resistant gram-negative infections.
The document includes guidance for the treatment of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa).
Authors Pranita D. Tamma, MD, director of the pediatric antimicrobial stewardship program and associate professor of pediatrics at Johns Hopkins Medicine, and colleagues noted that antimicrobial resistant